Allergan Asks Judge To Nix Off-Label Botox Suit
Allergan Inc. urged a California federal judge on Wednesday to toss a derivative shareholder suit accusing the pharmaceutical firm's board of improperly marketing the cosmetic drug Botox for off-label uses, saying...To view the full article, register now.
Already a subscriber? Click here to view full article